Keywords: Russia, Ukraine, Investment, Drug manufacturing, Reimbursement, Generics, PMR

Pharma companies to invest at least 1 billion euros in Russia; Ukraine outlook

Article | 24 March 2011

Because of Russia’s Pharma 2020 program regulations, designed to support local production, an increasing number of pharmaceutical companies are ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in